Clinton Bybee - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Codiak BioSciences Inc (CDAKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Codiak BioSciences Inc (CDAKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Codiak BioSciences Inc (CDAKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Impinj Inc (PI). Other recent insider transactions involving Impinj Inc (PI) include a net sale of 206,900 shares made by Diorio Chris Ph.d. , a net sale of 80,255 shares made by Jeffrey Dossett , and a net sale of 59,753 shares made by Cary Baker .

In summary, during the past 3 months, insiders sold 16,857 shares of Impinj Inc (PI) in total and bought 0 shares, with a net sale of 16,857 shares. During the past 18 months, 2,525,644 shares of Impinj Inc (PI) were sold and 4,513,179 shares were bought by its insiders, resulting in a net purchase of 1,987,535 shares.

Impinj Inc (PI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Beam Therapeutics Inc (BEAM). Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 258,765 shares made by John M. Evans , a net sale of 22,608 shares made by Christine Bellon , and a net sale of 114,188 shares made by Giuseppe Ciaramella .

In summary, during the past 3 months, insiders sold 113,636 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 113,636 shares. During the past 18 months, 1,372,228 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,372,228 shares.

Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Vir Biotechnology Inc (VIR). Other recent insider transactions involving Vir Biotechnology Inc (VIR) include a net sale of 3,124 shares made by , a net sale of 76,520 shares made by George A Scangos , and a net sale of 168,829 shares made by Backer Marianne De .

In summary, during the past 3 months, insiders sold 146,659 shares of Vir Biotechnology Inc (VIR) in total and bought 0 shares, with a net sale of 146,659 shares. During the past 18 months, 349,431 shares of Vir Biotechnology Inc (VIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 349,431 shares.

Vir Biotechnology Inc (VIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Denali Therapeutics Inc (DNLI). Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 24,356 shares made by Vicki L Sato , a net sale of 194,212 shares made by Steve E. Krognes , and a net sale of 114,066 shares made by Ryan J. Watts .

In summary, during the past 3 months, insiders sold 0 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 526,480 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 526,480 shares.

Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 35,274 shares made by David Roth , a net sale of 171,783 shares made by Nancy A Simonian , and a net sale of 37,803 shares made by Jason Haas .

In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 562,447 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 542,530 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Karuna Therapeutics Inc (KRTX). Other recent insider transactions involving Karuna Therapeutics Inc (KRTX) include a net sale of 40,000 shares made by Stephen K. Brannan ,

In summary, during the past 3 months, insiders sold 0 shares of Karuna Therapeutics Inc (KRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,000 shares of Karuna Therapeutics Inc (KRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 40,000 shares.

Karuna Therapeutics Inc (KRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 13,037 shares made by Arthur Tzianabos , a net sale of 7,280 shares made by Paul Alloway , and a net sale of 1,708 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,224 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,224 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Gossamer Bio Inc (GOSS). Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 293,570 shares made by Bryan Giraudo , a net purchase of 348,828 shares made by Faheem Hasnain , and a net sale of 5,926 shares made by Richard Aranda .

In summary, during the past 3 months, insiders sold 0 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,976 shares of Gossamer Bio Inc (GOSS) were sold and 729,000 shares were bought by its insiders, resulting in a net purchase of 683,024 shares.

Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Twist Bioscience Corp (TWST). Other recent insider transactions involving Twist Bioscience Corp (TWST) include a net sale of 15,242 shares made by Dennis Cho , a net sale of 91,691 shares made by Emily M. Leproust , and a net sale of 26,484 shares made by Paula Green .

In summary, during the past 3 months, insiders sold 28,522 shares of Twist Bioscience Corp (TWST) in total and bought 0 shares, with a net sale of 28,522 shares. During the past 18 months, 239,271 shares of Twist Bioscience Corp (TWST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 239,271 shares.

Twist Bioscience Corp (TWST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Scholar Rock Holding Corp (SRRK). Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net sale of 499,283 shares made by Edward H Myles , a net sale of 113,419 shares made by Mo Qatanani , and a net sale of 24,086 shares made by Caryn Parlavecchio .

In summary, during the past 3 months, insiders sold 273,226 shares of Scholar Rock Holding Corp (SRRK) in total and bought 0 shares, with a net sale of 273,226 shares. During the past 18 months, 4,066,891 shares of Scholar Rock Holding Corp (SRRK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,066,891 shares.

Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Unity Biotechnology Inc (UBX). Other recent insider transactions involving Unity Biotechnology Inc (UBX) include a net sale of 102,585 shares made by Anirvan Ghosh , a net sale of 20,351 shares made by Alexander Hieu Nguyen , and a net sale of 22,619 shares made by Lynne Marie Sullivan .

In summary, during the past 3 months, insiders sold 139,429 shares of Unity Biotechnology Inc (UBX) in total and bought 0 shares, with a net sale of 139,429 shares. During the past 18 months, 145,555 shares of Unity Biotechnology Inc (UBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 145,555 shares.

Unity Biotechnology Inc (UBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Pulmatrix Inc (PULM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pulmatrix Inc (PULM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pulmatrix Inc (PULM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Quanterix Corp (QTRX). Other recent insider transactions involving Quanterix Corp (QTRX) include a net sale of 5,500 shares made by Laurie J Olson , a net purchase of 47,000 shares made by David R Walt , and a net purchase of 19,000 shares made by Masoud Toloue .

In summary, during the past 3 months, insiders sold 0 shares of Quanterix Corp (QTRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,500 shares of Quanterix Corp (QTRX) were sold and 66,000 shares were bought by its insiders, resulting in a net purchase of 60,500 shares.

Quanterix Corp (QTRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Xtera Communications Inc (XCOMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xtera Communications Inc (XCOMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xtera Communications Inc (XCOMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of PhaseRx Inc (PZRXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseRx Inc (PZRXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhaseRx Inc (PZRXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Juno Therapeutics Inc (JUNO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Juno Therapeutics Inc (JUNO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Juno Therapeutics Inc (JUNO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Adesto Technologies Corp (IOTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adesto Technologies Corp (IOTS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adesto Technologies Corp (IOTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sage Therapeutics Inc (SAGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sage Therapeutics Inc (SAGE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sage Therapeutics Inc (SAGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Agios Pharmaceuticals Inc (AGIO). Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 8,310 shares made by Washburn Theodore James Jr. , a net sale of 31,815 shares made by James William Burns , and a net sale of 10,486 shares made by Sarah Gheuens .

In summary, during the past 3 months, insiders sold 15,455 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 15,455 shares. During the past 18 months, 236,881 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 236,881 shares.

Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Bellerophon Therapeutics Inc (BLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellerophon Therapeutics Inc (BLPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Bellerophon Therapeutics Inc (BLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net purchase of 100,961 shares made by Redmile Group, Llc , a net sale of 40,891 shares made by Cindy Tahl , and a net sale of 19,976 shares made by Bahram Valamehr .

In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 432,381 shares of Fate Therapeutics Inc (FATE) were sold and 442,594 shares were bought by its insiders, resulting in a net purchase of 10,213 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in bluebird bio Inc (BLUE). Other recent insider transactions involving bluebird bio Inc (BLUE) include a net sale of 13,140 shares made by Andrew Obenshain , a net sale of 12,617 shares made by Richard A Colvin , and a net sale of 11,243 shares made by Thomas J Klima .

In summary, during the past 3 months, insiders sold 510 shares of bluebird bio Inc (BLUE) in total and bought 0 shares, with a net sale of 510 shares. During the past 18 months, 2,985 shares of bluebird bio Inc (BLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,985 shares.

bluebird bio Inc (BLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc (NGSX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc (NGSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NeurogesX Inc (NGSX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net sale of 194,628,820 shares made by David E. Lazar , a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 194,628,820 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 194,628,820 shares. During the past 18 months, 194,628,820 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net sale of 194,620,864 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 75,070 shares made by Pushkal Garg , a net sale of 61,683 shares made by Yvonne Greenstreet , and a net sale of 31,577 shares made by Kevin Joseph Fitzgerald .

In summary, during the past 3 months, insiders sold 41,162 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 41,162 shares. During the past 18 months, 343,287 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 343,287 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Illumina Inc (ILMN). Other recent insider transactions involving Illumina Inc (ILMN) include a net purchase of 7,330 shares made by Jacob Thaysen , and a net sale of 315 shares made by Aimee L Hoyt .

In summary, during the past 3 months, insiders sold 0 shares of Illumina Inc (ILMN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 315 shares of Illumina Inc (ILMN) were sold and 7,330 shares were bought by its insiders, resulting in a net purchase of 7,015 shares.

Illumina Inc (ILMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in 908 Devices Inc (MASS). Other recent insider transactions involving 908 Devices Inc (MASS) include a net purchase of 24,928 shares made by Kevin J. Knopp , a net sale of 37,225 shares made by Griffith Joseph H. Iv , and a net sale of 31,724 shares made by Christopher D. Brown .

In summary, during the past 3 months, insiders sold 43,676 shares of 908 Devices Inc (MASS) in total and bought 0 shares, with a net sale of 43,676 shares. During the past 18 months, 108,925 shares of 908 Devices Inc (MASS) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 58,925 shares.

908 Devices Inc (MASS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Sana Biotechnology Inc (SANA). Other recent insider transactions involving Sana Biotechnology Inc (SANA) include a net purchase of 1,818,181 shares made by Keith Crandell , a net purchase of 1,818,181 shares made by Robert Nelsen , and a net purchase of 1,818,181 shares made by Arch Venture Fund X Overage, L.p. .

In summary, during the past 3 months, insiders sold 0 shares of Sana Biotechnology Inc (SANA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 690,912 shares of Sana Biotechnology Inc (SANA) were sold and 5,454,543 shares were bought by its insiders, resulting in a net purchase of 4,763,631 shares.

Sana Biotechnology Inc (SANA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Lyell Immunopharma Inc (LYEL). Other recent insider transactions involving Lyell Immunopharma Inc (LYEL) include a net purchase of 200,000 shares made by Sumant Ramachandra , a net purchase of 200,000 shares made by Charles W. Newton , and a net purchase of 175,000 shares made by Lynn Seely .

In summary, during the past 3 months, insiders sold 0 shares of Lyell Immunopharma Inc (LYEL) in total and bought 733,000 shares, with a net purchase of 733,000 shares. During the past 18 months, 0 shares of Lyell Immunopharma Inc (LYEL) were sold and 733,000 shares were bought by its insiders, resulting in a net purchase of 733,000 shares.

Lyell Immunopharma Inc (LYEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Clinton Bybee made no insider transaction in Neumora Therapeutics Inc (NMRA). Other recent insider transactions involving Neumora Therapeutics Inc (NMRA) include a net sale of 93,849 shares made by Robert A. Lenz , a net purchase of 271,309 shares made by Kristina Burow , and a net purchase of 271,309 shares made by Arch Venture Partners Xii, Llc .

In summary, during the past 3 months, insiders sold 38,076 shares of Neumora Therapeutics Inc (NMRA) in total and bought 0 shares, with a net sale of 38,076 shares. During the past 18 months, 248,099 shares of Neumora Therapeutics Inc (NMRA) were sold and 542,618 shares were bought by its insiders, resulting in a net purchase of 294,519 shares.

Neumora Therapeutics Inc (NMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.